A recent study based on ovarian cancer reported that kaempferol plays a role in the management of ovarian cancer through the regulation of the cell cycle as kaempferol-induced G2/M cell cycle arrest through the Chk2/p21/Cdc2 pathway and Chk2/Cdc25C/Cdc2 pathway. This evidence concerns the gene CDKN1A and ovarian cancer.